Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
RGNX - CASH FROM OPERATIONS
Cash from Operations RGNX - REGENXBIO Inc.
-218 M
LAST VALUE
-41.35%
2 YEAR CAGR
-25.29%
5 YEAR CAGR
-53.48%
10 YEAR CAGR